1 / 4

Digiceuticals Market

Analysis of Digiceuticals Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~33% During 2024-2036 and Attain ~USD 115 Billion by 2036

Utkarsha3
Download Presentation

Digiceuticals Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Analysis of Digiceuticals Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~33% During 2024- 2036 and Attain ~USD 115 Billion by 2036 Research Nester assesses the growth and market size of global digiceuticals market which is anticipated to be on account of the increasing adoption of digital health technologies, the rising prevalence of chronic diseases, and the increasing focus on preventive care New York – January 01, 2024 - Research Nester’s recent market research analysis on “Digiceuticals Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitors analysis and a detailed overview of the global digiceuticals market in terms of market segmentation by use, application, distribution channel and by region. Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-5540 Rise in chronic Disease Prevalence to Promote Global Market Share of Digiceuticals The global digiceuticals market is estimated to grow majorly on account of increase in number of people suffering from chronic diseases. Over 21% of the elderly population in India is reportedly affected by at least one chronic illness. In areas around 17% of older individuals experience chronic diseases while in urban areas this figure rises to 29%. Diabetes combined account for 68% of all chronic conditions. It is imperative to monitor and manage these diseases effectively. Digital health technologies, including Digiceuticals can play a role in facilitating the monitoring and management of chronic illnesses. Digiceuticals enable monitoring and tracking of vital signs like blood pressure, heart rate and

  2. glucose levels. They also offer personalized advice on managing ailments. Additionally they provide access, to healthcare professionals so that patients can receive timely guidance and care. Some of the major growth factors and challenges that are associated with the growth of the global digiceuticals market are: Growth Drivers: Increasing affordability of digital health solutions Rising prevalence of chronic diseases Challenges: …are some of the major factors anticipated to hamper the global market size of digiceuticals. (150 words with 2 challenges) Request for customization @ https://www.researchnester.com/customized-reports-5540 By application, the global digiceuticals market is segmented into diabetes management, substance abuse, pulmonary diseases, alcohol and smoking addiction, neurological disorders. The diabetes management segment is to garner a highest revenue by the end of 2036 by growing at a significant CAGR over the forecast period. The increase in segment growth can be attributed to factors, such as the rising prevalence of diabetes, increased awareness about preventive measures and government initiatives aimed at improving healthcare facilities for diabetic patients. According to projections by the IDF (International Diabetes Federation) it is estimated that by 2045 783 million adults, which equates to one in eight individuals will be living with diabetes. This represents a 46% increase. Digiceuticals offer a solution for people, with diabetes as they allow remote tracking of blood sugar levels and provide alerts when medication adjustments are needed.

  3. By region, the North America digiceuticals market is to generate the highest revenue by the end of 2036. The market in the region is expected to grow due the increase in chronic diseases, which has led to a higher demand for healthcare services. Additionally, there has been a rise in the use of health technologies and investments made by venture capitalists in healthcare innovation. Healthcare professionals have also started accepting therapeutics more widely. Furthermore, the Food and Drug Administration has approved digiceuticals that doctors can prescribe as treatments. This approval allows these treatments to be covered by health plans. An example of an FDA approved app is reset O, which offers therapy sessions for individuals dealing with addiction. These sessions are supervised by clinicians. Are currently being utilized in substance abuse facilities, across the country. This report also provides the existing competitive scenario of some of the key players of the Pear therapeutics Inc., Akili Interactive Labs, Inc., Chrono Therapeutics Inc., Click Therapeutics, Omada Health, Canary Health, Inc., Glooko, Inc., Propeller helath, Welldoc, Voluntis. Access our detailed report @ https://www.researchnester.com/reports/digiceuticals- market/5540 Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic

  4. minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919

More Related